DJIA 17,084.49 33.74 0.20%
NASDAQ 4,830.47 19.68 0.41%
S&P 500 2,014.89 1.46 0.07%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

8.04 0.43 (5.65%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVAX $8.04 5.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.67
Previous Close $7.61
Daily Range $7.43 - $8.08
52-Week Range $4.10 - $15.01
Market Cap $2.2B
P/E Ratio -19.03
Dividend (Yield) $0.00 (0.0%)
Volume 7,445,016
Average Daily Volume 7,346,334
Current FY EPS -$0.41




Drug Makers

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website:

News & Commentary Rss Feed

Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?

Regeneron Pharmaceuticals has won a BARDA agreement to develop a potential vaccine for the Ebola virus. How big of a deal is it for Regeneron investors today?

Trade-Ideas: Novavax (NVAX) Is Today's "Perilous Reversal" Stock

Benzinga's Top #PreMarket Gainers

Novavax's Respiratory Vaccine Study Data Fail to Impress

Why Shares of Novavax Inc Are Surging Higher Today

Positive phase 2 data and an $89 million grant sent the vaccine maker's stock higher.

Today's Dead Cat Bounce Stock Is Novavax (NVAX)

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

Novavax Rekindles Positive Momentum With RSV and Gates Grant

Heavy Trading On Novavax (NVAX) Before Market Open

See More NVAX News...

NVAX's Top Competitors

NVAX $8.04 (5.65%)
Current stock: NVAX
AMGN $149.59 (-0.21%)
Current stock: AMGN
GILD $100.65 (-0.16%)
Current stock: GILD
BIIB $269.16 (-3.83%)
Current stock: BIIB